Key facts

Invented name
  • Foster and associated names
  • Kantos and associated names
  • Kantos Master and associated names
  • Inuvair and associated names
Active Substance
  • Beclometasone dipropionate
  • formoterol fumarate dihydrate
Therapeutic area
Pneumology-allergology
Decision number
P/0159/2018
PIP number
EMEA-000548-PIP01-09-M08
Pharmaceutical form(s)
  • Inhalation powder
  • Pressurised inhalation (solution)
Condition(s) / indication(s)
Treatment of asthma
Route(s) of administration
Inhalation use
Contact for public enquiries

Chiesi Farmaceutici S.p.A.

Tel. +39 0521 2791
E-mail: info@chiesi.com

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date
Compliance procedure number
EMEA-C-000548-PIP01-09-M08
Compliance opinion date
Compliance outcome
Positive

Decision

P/0159/2018: EMA decision of 15 June 2018 on the acceptance of a modification of an agreed paediatric investigation plan for beclometasone (dipropionate)/formoterol (fumarate dihydrate) (Foster and associated names, Kantos and associated names, Inuvair..

How useful do you find this page?